MedPath

PTCCO2 Monitoring During Retroperitoneoscopic Urologic Surgery

Not Applicable
Completed
Conditions
Transcutaneous Carbon Dioxide Partial Pressure Monitoring
Retroperitoneoscopic Urologic Surgery
Registration Number
NCT03226041
Lead Sponsor
The First Affiliated Hospital with Nanjing Medical University
Brief Summary

To investigate the accuracy and correlation of estimating arterial CO2 pressure(PaCO2) using a transcutaneous CO2 pressure(PTCCO2) monitor in patients undergoing retroperitoneoscopic renal or adrenal surgery.

Detailed Description

30 patients undergoing retroperitoneoscopic renal or adrenal surgery were included in this study.Their PaCO2, PetCO2, and PTCCO2values were measured at 3 time points before and 30min, 60min after pneumoperitoneum and calculated the different between each measure(PetCO2 and PTCCO2) and PaCO2. Agreement among measures was assessed by the Bland-Altman method.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
32
Inclusion Criteria
  1. patients undergoing retroperitoneoscopic renal or adrenal surgery
  2. Age more than 16 years.
Exclusion Criteria
  1. Care taker unable or unwilling to give oral informed consent
  2. Patients with history of severe trauma, operations, smoking, and severe cardiovascular or respiratory diseases, such as coronary heart disease, congestive heart failure, or chronic obstructive pulmonary disease

4.Subject has a condition or allergy which would prohibit placing the probe 5.Subject has participated in a trial with any experimental drug or device trial within 30 days prior to enrollment in the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Bias and precision of the transcutaneous carbon dioxide measurements60 minutes

correlation and agreement between PetCO2 and PaCO2 and PTCCO2

Secondary Outcome Measures
NameTimeMethod
complication: appearance of signs of thermal injury (redness, skin erythema, blisters, necrosis) under application of transcutaneous sensor temperatures of 44°C )60 minutes

While the sensor temperatures heated to 44°C, the skin will be closely observed for any kind of thermic tissue damage

Trial Locations

Locations (1)

The First Affiliated Hospital of Nanjing Medical University

🇨🇳

Nanjing, Jiangsu, China

The First Affiliated Hospital of Nanjing Medical University
🇨🇳Nanjing, Jiangsu, China

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.